A Villegas Selected Research

A Villegas Research Topics

3	Polycythemia (Erythrocytosis) 03/2009 - 12/2000
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
2	alpha-Thalassemia 08/2001 - 08/2001
1	Disease Progression 01/2022
1	Autosomal Dominant 5 Deafness 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2012
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2011
1	Anemia 05/2011
1	Fatigue 05/2011
1	Iron Deficiencies 05/2011
1	Neoplasms (Cancer) 05/2011
1	Headache (Headaches) 05/2011
1	Type 2 Diabetes Mellitus (MODY) 08/2009
1	Persistent Infection 12/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2003
1	CADASIL 07/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2001
1	Intellectual Disability (Idiocy) 08/2001
1	Pathologic Complete Response 07/2001
1	beta-Thalassemia (Cooley's Anemia) 12/2000

3	Oxygen (Dioxygen)IBA 03/2009 - 12/2000
2	durvalumabIBA 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 12/2003 - 08/2001
1	PlatinumIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2016
1	BenzodiazepinesIBA 05/2012
1	Darbepoetin alfa (Aranesp)FDA Link 05/2011
1	HematinicsIBA 05/2011
1	Genetic Markers (Genetic Marker)IBA 08/2009
1	EnzymesIBA 12/2003
1	HemosiderinIBA 12/2003
1	IronIBA 12/2003
1	Antiviral Agents (Antivirals)IBA 12/2003
1	Epidermal Growth Factor (EGF)IBA 07/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2001
1	RNA Splice SitesIBA 08/2001
1	Protein Isoforms (Isoforms)IBA 07/2001
1	Hemoglobins (Hemoglobin)IBA 12/2000
1	hemoglobin JohnstownIBA 12/2000

2	Chemoradiotherapy 01/2022 - 01/2020
2	Therapeutics 05/2011 - 12/2003